Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study.

Barnett, Michael;Bergsland, Niels;Weinstock-Guttman, Bianca;Butzkueven, Helmut;Zivadinov, Robert;et.al.
(2021) NeuroImage: Clinical — Vol. 32, n° 1, p. 102802 [1-10] (2021)

Files

main.pdf
  • Open Access
  • Adobe PDF
  • 2.19 MB

Details

Authors
  • Barnett, Michael
    Author
  • Bergsland, Niels
    Author
  • Weinstock-Guttman, Bianca
    Author
  • Butzkueven, Helmut
    Author
  • Author
  • Zivadinov, Robert
    Author
Show more
Abstract
(en) BACKGROUND: Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up of multiple sclerosis (MS) patients on clinical routine datasets. OBJECTIVE: To determine the feasibility of T2-FLAIR-only measures of lateral ventricular volume (LVV) and salient central lesion volume (SCLV), as markers of disability progression (DP) in MS. METHODS: A total of 3,228 MS patients from 9 MSBase centers in 5 countries were enrolled. Of those, 2,875 (218 with clinically isolated syndrome, 2,231 with relapsing-remitting and 426 with progressive disease subtype) fulfilled inclusion and exclusion criteria. Patients were scanned on either 1.5 T or 3 T MRI scanners, and 5,750 brain scans were collected at index and on average after 42.3 months at post-index. Demographic and clinical data were collected from the MSBase registry. LVV and SCLV were measured on clinical routine T2-FLAIR images. RESULTS: Longitudinal LVV and SCLV analyses were successful in 96% of the scans. 57% of patients had scanner-related changes over the follow-up. After correcting for age, sex, disease duration, disability, disease-modifying therapy and LVV at index, and follow-up time, MS patients with DP (n = 671) had significantly greater absolute LVV change compared to stable (n = 1,501) or disability improved (DI, n = 248) MS patients (2.0 mL vs. 1.4 mL vs. 1.1 mL, respectively, ANCOVA p < 0.001, post-hoc pair-wise DP vs. Stable p = 0.003; and DP vs. DI, p = 0.002). Similar ANCOVA model was also significant for SCLV (p = 0.03). CONCLUSIONS: LVV-based atrophy and SCLV-based lesion outcomes are feasible on clinically acquired T2-FLAIR scans in a multicenter fashion and are associated with DP over mid-term.
Affiliations

Citations

Barnett, M., Bergsland, N., Weinstock-Guttman, B., Butzkueven, H., Kalincik, T., Desmond, P., Gaillard, F., Van Pesch, V., Ozakbas, S., Rojas, J. I., Boz, C., Altintas, A., Wang, C., Dwyer, M. G., Yang, S., Jakimovski, D., Kyle, K., Ramasamy, D. P., & Zivadinov, R. (2021). Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study. NeuroImage: Clinical, 32(1), 102802 [1-10]. https://doi.org/10.1016/j.nicl.2021.102802 (Original work published 2021)